MedTrace Logo

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

NCT01113710 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 687

Last updated 2012-09-28

Study results available
· View outcomes & findings →

Summary

This non-interventional observational study is designed to gain data for Neupro® in restless legs syndrome (RLS) under real life conditions in line with the summary of product characteristics (SmPC) related to effectiveness, tolerability and switching practice from other dopaminergic drugs as well as titration schemes.

Conditions

  • Idiopathic Restless Legs Syndrome

Interventions

DRUG

Neupro®

Neupro® is the exposure/intervention of interest in this non-interventional study.

Sponsors & Collaborators

  • UCB Pharma

    lead INDUSTRY

Principal Investigators

  • UCB Clinical Trial Call Center · +1 877 822 9493 (UCB)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113710 on ClinicalTrials.gov